Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Rational Emotive Behavior Therapy01:24

Rational Emotive Behavior Therapy

Cognitive-behavioral therapies (CBTs) are grounded in the belief that our thoughts profoundly influence our emotions and actions. Advocates of CBT emphasize three core assumptions: first, that cognitions are identifiable and measurable; second, that they are central to psychological functioning; and third, that irrational or maladaptive beliefs can be replaced with rational and adaptive ones. This transformative approach to therapy has paved the way for specific models such as Albert Ellis's...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Functioning assessment short test for autism (FAST-A): a tool to evaluate adaptive functioning in autistic adults" [European Neuropsychopharmacology, 112, 112887].

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same author

Brain correlates of cognitive reserve in offspring of patients with schizophrenia or bipolar disorder.

European child & adolescent psychiatry·2026
Same author

Longitudinal Impact of Birthweight and its Polygenic Risk Score on Glucose and Antipsychotic-Induced Weight Gain in First Episode Psychosis.

Schizophrenia bulletin·2026
Same author

Functioning assessment short test for autism (FAST-A): a tool to evaluate adaptive functioning in autistic adults.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same author

20-year pharmacological treatment trajectories in a cohort of patients with bipolar disorder.

Psychiatry research·2026
Same author

Adverse childhood experiences and risk of non-mental medical diseases in adulthood: an umbrella review.

EClinicalMedicine·2026
Same journal

Relationship between Mindful Eating and Academic Burnout Syndrome in Medical Undergraduate Students: A Cross-Sectional Study.

Clinical practice and epidemiology in mental health : CP & EMH·2026
Same journal

Generalized Isometric Sustained Contraction During Apnea Combined with Relaxation for Anxiety: A First Evaluation.

Clinical practice and epidemiology in mental health : CP & EMH·2026
Same journal

From Clinic to Home: Empowering Parents with Naturalistic Developmental Behavioral Interventions for Autism Spectrum Disorders.

Clinical practice and epidemiology in mental health : CP & EMH·2026
Same journal

Self-selected Recovery in High-intensity Interval Training Promotes Positive Responses in Affect, Pleasure, and Mood in Young People.

Clinical practice and epidemiology in mental health : CP & EMH·2026
Same journal

Cost-Effectiveness of Transcranial Magnetic Stimulation and Virtual Reality-Based Cognitive Remediation for Depressive Symptoms among Cancer Patients: Protocol for a Three-Arm Randomized Controlled Trial.

Clinical practice and epidemiology in mental health : CP & EMH·2026
Same journal

Excessive Daytime Sleepiness and Risk of Sleep Apnea: A Retrospective Analysis of Peruvian Adults.

Clinical practice and epidemiology in mental health : CP & EMH·2026
See all related articles

Related Experiment Video

Updated: May 31, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Functional remediation for bipolar disorder.

Anabel Martínez-Arán1, Carla Torrent, Brisa Solé

  • 1Early Onset Psychosis Program & Bipolar Disorders Program, Clinical Institute of Neuroscience, Hospital Clinic of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain.

Clinical Practice and Epidemiology in Mental Health : CP & EMH
|June 21, 2011
PubMed
Summary
This summary is machine-generated.

Bipolar disorder significantly impacts cognitive functions like memory and attention, worsening with illness progression. Early cognitive remediation is crucial for improving functioning in patients with bipolar illness.

Keywords:
Neurocognitionbipolar disorder.functional remediation

Related Experiment Videos

Last Updated: May 31, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Area of Science:

  • Neuroscience
  • Psychiatry
  • Cognitive Psychology

Background:

  • Neurocognitive impairment is a central characteristic of bipolar disorder.
  • Key affected domains include verbal memory, attention, and executive functions.
  • Cognitive deficits correlate with functional remission difficulties and illness progression.

Purpose of the Study:

  • To highlight the impact of neurocognitive impairment in bipolar disorder.
  • To emphasize the link between cognitive deficits and functional outcomes.
  • To advocate for adapted cognitive remediation strategies for bipolar disorder.

Main Methods:

  • Review of existing literature on neurocognitive deficits in bipolar disorder.
  • Analysis of the relationship between cognitive impairment and functional remission.
  • Exploration of cognitive remediation strategies from related conditions.

Main Results:

  • Neurocognitive impairment, particularly in memory, attention, and executive functions, is a core feature of bipolar disorder.
  • Cognitive deficits are associated with poorer functional outcomes and increased difficulty achieving remission.
  • Cognitive remediation strategies, successful in other conditions, require adaptation for bipolar disorder.

Conclusions:

  • Early intervention with functional remediation is essential for managing cognitive deficits in bipolar disorder.
  • Functional remediation should integrate neurocognitive techniques, psychoeducation, and ecological problem-solving.
  • Adapting cognitive remediation strategies holds promise for improving patient functioning in bipolar disorder.